LLY Earnings

LLY reported its earnings on 2026-04-30, showcasing a revenue of 19.80B against an estimate of 17.78B, resulting in a 11.36% surprise. The EPS was 8.55, surpassing the expected 7.06 by 21.1%. The stock experienced a 9.8% price change on the earnings day and a 16.17% change over the next five days, reflecting market reactions to the results.

Following LLY's earnings announcement on 2026-04-30, the stock price moved by 9.8% on the day of the release. Over the subsequent five days, it saw a 16.17% change. Historically, LLY's stock price tends to shift by an average of -1.22% in the 10 days leading up to earnings and 3.09% in the 10 days following, providing insight into potential market.

For 2026/Q2, analysts estimate LLY's annual revenue to reach 18.62B, while the EPS is projected at 7.98. These estimates reflect recent revisions, with revenue estimates unchanged by 0% and EPS estimates unchanged by 0% over the past three months, indicating analyst expectation in the company's performance.

The correlation between LLY's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock's fundamentals. Over the past three months, revenue estimates for FY2025 were unchanged by 0%, while EPS estimates moved unchanged by 0%. This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, LLY's stock price typically moves by -1.22% in the 10 days before its earnings and 3.09% in the 10 days after. For the upcoming 2026/Q2 earnings, analysts expect an EPS of 7.98 and revenue of 18.62B.

The earnings call summary indicates strong financial performance, with revenue growth and solid earnings projections. Product development is robust, with new launches and pipeline expansion. Market strategy is well-defined, focusing on Medicare activation and employer programs. Expenses are increasing due to R&D, but financial health appears strong with good margins. Shareholder return plans are not explicitly mentioned, but the overall sentiment from the Q&A supports a positive outlook. The combination of optimistic guidance, strategic market expansion, and innovative product launches suggests a likely positive stock price movement.